Lexicon Pharmaceuticals Inc (LXRX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

8800 TECHNOLOGY FOREST PLACE THE WOODLANDS, TX 77381

Operates as a biopharmaceutical company that discovers and develops breakthrough treatments for human disease. The company uses gene knockout technology to systematically discover the physiological functions of genes in living mammals, or in vivo.

Data as of 2020-08-01
Market Cap207.785 Million Shares Outstanding107.106 Million Avg 30-day Volume2.514 Million
P/E Ratio3.0 Dividend Yield EPS0.67
Price/Sales0.668 Price cash flow ratio2.0 Price free cash flow ratio1.5
Book Value0.51 Price to Tangible Book-23.69 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.034295
BETA1.10219 52-week High/Low5.33 / 1.125 Stddev0.256072
View SEC Filings from LXRX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 0 (0.0%)
13F Filers holding this stock: 111 32 (2.1%)
Aggregate 13F shares on 03/31/2020: 104.804 Million 24.806 Million
Aggregate 13F shares on 12/31/2019: 107.179 Million 24.786 Million
Percent change: -2.22% 0.08%
Funds creating new positions: 21 9
Funds Adding to an existing position: 37 16
Funds closing out their position: 22 9
Funds reducing their position: 26 6
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LXRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LXRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GREGORY JULIA P

  • Director
0 2020-07-23 0

SANDS ARTHUR T PRESIDENT, CEO

  • Officer
  • Director
908,333 2020-07-23 0

HOWSON TAMAR D

  • Director
0 2020-07-02 0

DEBBANE RAYMOND

  • Director
37,266 2020-06-29 3

SOBECKI CHRISTOPHER J

  • Director
57,315 2020-06-29 3

COATS LONNEL

  • Director
3,562 2020-06-24 5

BANSAL AJAY PFO;CFO/UROVANT SCIENCES, INC.

  • Officer
138,659 2020-05-01 0

BARKER SAM L

  • Director
55,653 2020-04-24 1

AMOUYAL PHILIPPE

  • Director
16,368 2020-04-24 1

LEFKOWITZ ROBERT J MD

  • Director
16,368 2020-04-24 1

NIES ALAN S

  • Director
17,082 2020-04-24 1

PALANTONI FRANK

  • Director
16,368 2020-04-24 1

SWAIN JUDITH L

  • Director
16,368 2020-04-24 1

MAIN ALAN J EVP, COMMERCIAL SUPPLY OPS

  • Officer
104,640 2020-04-22 3

WADE JEFFREY L EVP, CORP ADM AFFAIRS AND CFO

  • Officer
115,495 2020-04-22 3

TESSMER JAMES F VP, FINANCE & ACCOUNTING

  • Officer
65,127 2020-04-22 3

LAPUERTA PABLO EVP AND CMO

  • Officer
85,719 2020-04-22 3

TYLE PRAVEEN EVP, R&D

  • Officer
69,344 2020-04-22 3

SANTINI ALEXANDER A EVP AND CCO

  • Officer
55,584 2020-04-22 4

CRUM BRIAN T VP, GENERAL COUNSEL & SECR.

  • Officer
49,732 2020-04-22 4

NORTHCOTT JOHN SVP & CHIEF COMMERCIAL OFFICER

  • Officer
200,000 2019-12-02 0

INVUS PUBLIC EQUITIES, L.P.

ARTAL INTERNATIONAL S.C.A.

ARTAL INTERNATIONAL MANAGEMENT S.A.

ARTAL GROUP S.A.

WESTEND S.A.

STICHTING ADMINISTRATIEKANTOOR WESTEND

MINNE PASCAL

INVUS, L.P.

INVUS ADVISORS, L.L.C.

INVUS PUBLIC EQUITIES ADVISORS, LLC

  • Director
  • 10% Owner
60,240,864 2018-06-27 0

ARTAL INTERNATIONAL S.C.A.

ARTAL INTERNATIONAL MANAGEMENT S.A.

ARTAL GROUP S.A.

WESTEND S.A.

STICHTING ADMINISTRATIEKANTOOR WESTEND

MINNE PASCAL

  • 10% Owner
0 2018-05-23 0

INVUS C.V.

ULYS, L.L.C.

DEBBANE RAYMOND

  • Director
  • 10% Owner
30,283,190 2014-12-12 0

ZAMBROWICZ BRIAN P EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
278,703 2014-02-28 0

ULYS, LLC

INVUS, L.P.

INVUS PUBLIC EQUITIES, LP

INVUS, CV

INVUS ADVISORS, L.L.C.

INVUS PUBLIC EQUITIES ADVISORS, LLC

DEBBANE RAYMOND

  • Director
  • 10% Owner
255,925,427 2011-12-22 3

ULYS, LLC

INVUS, L.P.

INVUS ADVISORS, L.L.C.

INVUS, CV

DEBBANE RAYMOND

  • 10% Owner
165,110,497 2010-03-19 3

TRAGASH STEVEN ALAN VP, CORPORATE AFFAIRS

  • Officer
0 2010-02-15 0

BROWN PHILIP M SVP, CLINICAL DEVELOPMENT

  • Officer
27,306 2010-02-12 0

WILTSEY KATHLEEN M

  • Director
0 2010-01-04 0

ULYS, LLC

INVUS, L.P.

INVUS ADVISORS, L.L.C.

DEBBANE RAYMOND

  • 10% Owner
70,840,291 2009-10-14 3

ISHIMOTO LANCE K SVP, INTELLECTUAL PROPERTY

  • Officer
0 2008-02-07 0

PIGGOTT JAMES R PHD SVP OF PHARM BIO

  • Officer
0 2008-02-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments